8-KEarnings & ResultsMaterial AgreementsExhibits & Filings

DEXCOM INC 8-K Report, Material Agreement (May 6, 2009)

Filed May 6, 2009For Securities:DXCM

Summary

This Form 8-K filing from DexCom, Inc. (DXCM) on May 6, 2009, primarily details two key events impacting the company's collaboration and financial reporting. Firstly, an amendment to a Collaboration Agreement with Edwards Lifesciences LLC reduces DexCom's development funding obligation by $1,500,000, as Edwards will now lead and fund a portion of the clinical trials for the first-generation product. Secondly, the filing incorporates by reference a press release announcing DexCom's financial results for the quarter ended March 31, 2009. While the specifics of these financial results are not detailed within the 8-K text itself (they are in the referenced Exhibit 99.01), this indicates a routine disclosure of quarterly performance. Investors should note the impact of the revised collaboration terms on future development costs and refer to the accompanying press release for a comprehensive understanding of the first-quarter financial performance.

Key Highlights

  • 1DexCom amended its Collaboration Agreement with Edwards Lifesciences LLC.
  • 2Edwards Lifesciences will now lead and fund a portion of clinical trials for DexCom's first-generation product.
  • 3DexCom's development funding obligation to Edwards is reduced by $1,500,000.
  • 4The amendment simplifies the allocation of responsibilities and funding for critical clinical trials.
  • 5The filing includes a press release announcing DexCom's financial results for the quarter ended March 31, 2009.
  • 6The financial results press release is furnished as Exhibit 99.01 and is incorporated by reference.

Frequently Asked Questions

The amendment reduces DexCom's development funding obligation by $1,500,000 because Edwards Lifesciences will now take the lead and fund a portion of the clinical trials related to the first-generation product.

The press release, furnished as Exhibit 99.01, contains DexCom's financial results for the quarter ended March 31, 2009, and other relevant business information. The specifics are not detailed in the 8-K text itself.

The Letter Agreement amending the Collaboration Agreement was entered into on May 5, 2009. The press release announcing financial results was issued on May 6, 2009.

No, the information in Item 2.02 and Exhibit 99.01 is furnished, not filed. This means it is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.